OBJECTIVES Hidradenitis suppurativa (HS) is a chronic inflammatory disease with skin symptoms, including painful abscesses and nodules, which can rupture and extract malodorous pus. We aimed to elucidate the impact of HS on health-related quality of life (hrQoL) through one dermatology-specific and two condition-specific instruments, as well as to investigate the correlation of the instruments. METHODS A cross-sectional one-center pilot study was conducted with 26 Finnish patients with HS. Impact on hrQoL was measured using the Dermatology Life Quality Index (DLQI) and the HS-specific Hidradenitis Suppurativa Impact Assessment (HSIA). The impact of HS was further explored with the Hidradenitis Suppurativa Symptom Assessment (HSSA). The HSIA-and HSSA-instruments (Kimball et al., ISPOR 2015) are self-administered questionnaires assessing the impact and symptomatology of HS over a 7-day-period.
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• The objective of this study was to elucidate the impact of HS on hrQoL through one dermatology-specific and two condition-specific instruments, as well as to investigate the correlation of the instruments.
STUDY DESIGN
• A single-center cross-sectional study was conducted with 26 adult patients with a confirmed diagnosis of HS ICD-10 (International Classification of Diseases, 10 th revision) diagnosis code L73.2 ( Figure 1 ).
CHART REVIEW
• Medical charts of patients with HS who were included in the study were screened for pre-specified data on demographics, social and economic status, personal and familial HS history, lifestyle (tobacco, alcohol), comorbidities, clinical presentation, and severity of HS.
• Data on burden on the healthcare system (e.g., HS-related surgeries) were collected.
PHYSICAL EXAMINATION AND PATIENT INTERVIEW
• At this stage, the physician verified the diagnosis of HS, mapped current disease status, and possible comorbidities.
• Patients ranked 10 HS-related symptoms according to the impact on their everyday life.
• Patients were also asked about diagnostic delay, HS-related surgeries, and healthcare resource use.
PATIENT QUESTIONNAIRES
• Patients were asked to complete a comprehensive set of selfassessment questionnaires, the Work Productivity and Activity Impairment-Specific Health Problem (WPAI-SHP), Dermatology Life Quality Index (DLQI), Beck Depression Inventory (BDI-21), 15D Instrument (15D), HSSA, and HSIA, at home before the patient visit. The results from the chart review, physical examination, and patient interviews will be published elsewhere. Only the results from the DLQI, HSIA, and HSSA patient questionnaires are presented in this poster.
• The DLQI is a validated dermatology-specific 10-item selfadministered questionnaire (5) . The HSIA and HSSA are 16-and 9-item self-administered questionnaires developed to assess the impact of HS over a 7-day period. The HSIA include 18 items, but only 16 are used to calculate the score. The HSIA and HSSA questionnaires have been previously presented by Kimball et al. (6) .
ASSESSMENTS
The questions in the DLQI, HSIA, and HSSA questionnaires are as follows:
DLQI:
Over the last week,… 1. How itchy, sore painful or stinging has your skin been? 2. How embarrassed or self conscious have you been because of your skin? 3. How much has your skin interfered with you going shopping or looking after your home or garden? 4. How much has your skin influenced the clothes you wear? 5. How much has your skin affected any social or leisure activities? 6. How much has your skin made it difficult for you to do any sport? 7. Has your skin prevented you from working or studying? If "No", over the last week how much has your skin been a problem at work or studying? 8. How much has your skin created problems with your partner or any of your close friends or relatives? 9. How much has your skin caused any sexual difficulties? 10. How much of a problem has the treatment for your skin been, for example by making your home messy, or by taking up time?
HSIA:
Over the past 7 days,… • Compared with DLQI, correlation coefficients for HSIA and HSSA were 0.92 and 0.61 (Table 3 ).
• All p values were derived using stepwise regression models. ICD-10 diagnosis L73.2 ≥6 months before study initiation n 69
• Approval for this study was granted by the Ethical Committee of HUCH Internal Medicine (191/13/03/01/15). All participants provided informed consent. To protect patient confidentiality, all personally identifiable information was de-identified at all stages of the study. The study was divided into three sections (Figure 2 ) . • Overall, 69 patients with HS were seen between January 1, 2014, and July 1, 2015. All medical files were reviewed for qualification: patients had to be a minimum of 18 years of age, diagnosed with HS at least 6 months prior to inclusion, and able to provide informed consent. • The correlation between a dermatology-specific (DLQI) and two condition-specific instruments (HSIA and HSSA) is reported for the first time.
Figure 1. Patient inclusion flow chart
METHODS (CONTINUED)
• This is the first study to present hrQoL data for Finnish patients with HS.
• Results suggest that HS strongly impacts patients' hrQoL, with women more affected than men.
• Results show a statistically significant relationship between Hurley stage and DLQI, HSIA, and HSSA scores.
• Both the HSSA and HSIA exhibit a statistically significant correlation with the DLQI.
• Due to the restricted sample size of this study, our aim is to confirm the results in a nationwide study.
STATISTICAL METHODS
• Descriptive statistics, stepwise regression models, and Pearson correlation coefficients were used for statistical analyses. Patients' characteristics are presented as means and SDs for continuous variables and frequencies and proportions for categorical variables.
• Stepwise regression analysis was used to estimate how gender, age, smoking (pack years), alcohol consumption (grams per week), body mass index, overall number of comorbidities, severity of the disease (Hurley staging, number of affected locations) explained the HSSA, HSIA, and DLQI scores, using p=0.15 for inclusion criteria in the model. A 2-sided p-value of 0.05 was considered statistically significant.
CONCLUSIONS
